Stock Details
LH is Laboratory Corporation of America Holdings's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 242.50$. Average daily volumn in 3 months 883.7k. Market cap 22.34B



Stock symbol : LH. Exchange : NYSE. Currency : USD
Lastest price : 240.94$. Total volume : 436.03k. Market state PRE
Click reload if you want to check the lastest price on market!!!

Laboratory Corporation of America Holdings (LH)
Last Price
240.94$
Change
6.58
Volume
436.03k

Previous Close234.36
Open235.32
Day Range234.71-241.45
Bid0.00 x 800
Ask255.00 x 800
Volume436.03k
Average Volume883.7k
Market Cap22.34B
Beta1.04
52 Week Range212.40-317.17
Trailing P/E10.75
Foward P/E13.14
Dividend (Yield %)1.20%
Ex-Dividend Date2022-05-18



Financial Details


According to Laboratory Corporation of America Holdings's financial reports the company's revenue in 2021 were 16.12B an increase( +23.08%) over the years 2020 revenue that were of 13.98B. In 2021 the company's total earnings were 2.38B while total earnings in 2020 were 1.56B( +100%).


Loading ...



Organization

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other... substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations. It offers end-to-end drug development, medical device, and diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, biopharmaceutical companies, physicians and other healthcare providers, hospitals and health systems, governmental agencies, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, and independent clinical laboratories. Laboratory Corporation of America Holdings has a collaboration agreement with Tigerlily Foundation to increase clinical trial diversity for women of color. The company was founded in 1971 and is headquartered in Burlington, North Carolina.

Market Cap:
22.34B
Revenue:
16.12B
Total Assets:
20.39B
Total Cash:
1.47B


News about "Laboratory Corporation of America Holdings"

retirement-systems-of-alabama-trims-holdings-in-laboratory-co-of-america-holdings-nyselh-image

Retirement Systems of Alabama Trims Holdings in Laboratory Co. of America Holdings (NYSE:LH)

Source from : Defense World - 11 hours ago

Retirement Systems of Alabama cut its holdings in Laboratory Co. of America Holdings (NYSE:LH โ€“ Get Rating) by 2.7% during the first quarter, according to its most recent 13F filing with the ...See details»


transcend-capital-advisors-llc-invests-280000-in-laboratory-co-of-america-holdings-nyselh-image

Transcend Capital Advisors LLC Invests $280,000 in Laboratory Co. of America Holdings (NYSE:LH)

Source from : Defense World - 10 hours ago

Transcend Capital Advisors LLC purchased a new position in shares of Laboratory Co. of America Holdings (NYSE:LH โ€“ Get Rating) during the 1st quarter, according to the company in its most recent 13F ...See details»


Laboratory Corporation of America Holdings (LH): These Shares are Poised for Major Movement

Source from : investchronicle - 1 days ago

At the end of the latest market close, Laboratory Corporation of America Holdings (LH) was valued at $234.36. In that particular session, Stock kicked-off at the price of $235.32 while reaching the ...See details»


Laboratory Corporation of America Holdings (NYSE: LH) Is Up 2.81% โ€“ Is It Ready For A Rally?

Source from : stocksregister - 1 days ago

Laboratory Corporation of America Holdings (NYSE:LH) price closed higher on Friday, July 01, jumping 2.81% above its previous close. >> 5 Best Growth Stocks for 2022 << >> 5 Best Growth Stocks for 202 ...See details»


Laboratory Corp of America Holdings - Stock Dividends LH

Source from : Morningstar%2c Inc. - 1 days ago

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.See details»


laboratory-co-of-america-holdings-nyselh-shares-purchased-by-nordea-investment-management-ab-image

Laboratory Co. of America Holdings (NYSE:LH) Shares Purchased by Nordea Investment Management AB

Source from : ETF Daily News - 12 days ago

Consolidated Planning Corp acquired a new stake in shares of Laboratory Co. of America during the third quarter worth about $26,000. Arrow Financial Corp lifted its holdings in shares of Laboratory Co ...See details»


gateway-investment-advisers-llc-has-385000-holdings-in-laboratory-co-of-america-holdings-nyselh-image

Gateway Investment Advisers LLC Has $385,000 Holdings in Laboratory Co. of America Holdings (NYSE:LH)

Source from : ETF Daily News - 8 days ago

State Street Corp boosted its holdings in shares of Laboratory Co. of America by 2.7% in the fourth quarter. State Street Corp now owns 4,423,702 shares of the medical research companyโ€™s stock valued ...See details»


What Is Laboratory Corporation of America Holdings's (NYSE:LH) Share Price Doing?

Source from : Yahoo News - 15 days ago

Today we're going to take a look at the well-established Laboratory Corporation of America Holdings (NYSE:LH). The company's stock received a lot of attention from a substantial price movement on the ...See details»


Laboratory Corporation of America Holdings Enters Oversold Territory

Source from : Nasdaq - 22 days ago

Laboratory Corporation of America Holdings (Symbol: LH) presently has an above average rank, in the top 50% of the coverage universe, which suggests it is among the top most "interesting" ideas ...See details»


Here's Why Investors Should Retain LabCorp (LH) Stock for Now

Source from : Nasdaq - 14 days ago

Laboratory Corporation of America Holdings or LabCorp LH is gaining from the strength in its Drug Development business. The companyโ€™s continued commitment to pandemic support instills optimism.See details»


labcorp-lh-to-strengthen-laboratory-footprint-in-japan-image

LabCorp (LH) to Strengthen Laboratory Footprint in Japan

Source from : Yahoo Finance - 1 days ago

Drug Development arm, in collaboration with BML, will open a 4,000-square meters lab facility in Kawagoe for global clinical trials.See details»


At 7.5% CAGR, Clinical Laboratory Test Market to hit USD 320.7 Billion in 2028, Says Brandessence Market Research

Source from : Benzinga.com - 4 days ago

Laboratory Corporation of America Holdings (LabCorp), QIAGEN, Tulip Diagnostics (P) Ltd., Quest Diagnostics, Siemens Healthcare Private Limited, Merck KgaA Biosino Bio-technology, and Sonic ...See details»


5 'Strong Buy' BofA Securities Value 10 Stocks With Very Dependable Dividends

Source from : 24/7 Wall St - 7 days ago

Clinical lab testing never goes out of style, and this company is a leader. Laboratory Corp. of America, Holdings (NYSE: LH) operates as an independent clinical laboratory company worldwide.See details»


Labcorp Expanding Japanese Drug, CDx Development Laboratory Capacity Under BML Collaboration

Source from : 360dx - 6 days ago

The partners are building a new Japanese facility that will provide new space and laboratory capabilities for clinical trials managed by Labcorp Drug Development.See details»